{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T12:38:01Z","timestamp":1774528681565,"version":"3.50.1"},"reference-count":0,"publisher":"Pakistan Medical Association","issue":"4","license":[{"start":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T00:00:00Z","timestamp":1684972800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Pak Med Assoc"],"abstract":"<jats:p>Objective: To explore if the oral lesions in coronavirus disease-2019 patients are caused by the drugs used in the treatment or by the virus itself.Method: The cross-sectional study was conducted from September 2020 to September 2021 at the Kafrelsheikh University Hospital, Egypt, and comprised coronavirus disease-2019 patients of either gender aged 20-60 years having severe pneumonia and breathing difficulties who had no comorbidities. Based on the level of interleukin-6 and procalcitonin, the patients were classified into high group I receiving tocilizumab and methylprednisolone, medium group II receiving methylprednisolone alone, and low group III receiving antiviral drugs. The oral manifestations wererecorded at the time of admission before treatment and at 2 weeks after the respective treatment. Data was analysed using SPSS 20.Results: Of the 90 patients, 30(33.3%) were in group I; 16(%) males and 14(%) females with mean age 44.82\u00b16.10 years. Group II had 27(%) patients; 14(%) males and 13(%) females with mean age 43.74\u00b14.87 years. Group III had 33(%) patients; 9(%) males and 14(%) females with mean age 42.66\u00b12.51 years (p&gt;0.05). There was no significant difference among the groups at baseline and after 2 weeks of treatment regarding oral manifestations. Intragroup comparison demonstrated a significant difference in the two values in all the three groups (p&lt;0.05).Conclusion: Oral lesions in coronavirus disease-2019 patients were caused by the virus itself rather than the drugs used in its treatment.Keywords: Tocilizumab, Dentists, Methylprednisolone, COVID-19.<\/jats:p>","DOI":"10.47391\/jpma.egy-s4-38","type":"journal-article","created":{"date-parts":[[2023,6,4]],"date-time":"2023-06-04T04:29:25Z","timestamp":1685852965000},"page":"S191-S194","source":"Crossref","is-referenced-by-count":1,"title":["Effect of corticosteroid and immune-suppressive drugs on oral manifestations in hospitalized COVID-19 patients"],"prefix":"10.47391","volume":"73","author":[{"family":"Ahmed Mohamed Al Elgendy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Enas Ahmed Elgendy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Marwa Sabry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Mohamed Kamal Salama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Tamer Aboshady","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"26547","published-online":{"date-parts":[[2023,5,25]]},"container-title":["Journal of the Pakistan Medical Association"],"original-title":[],"link":[{"URL":"https:\/\/ojs.jpma.org.pk\/index.php\/public_html\/article\/download\/9853\/2402","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ojs.jpma.org.pk\/index.php\/public_html\/article\/download\/9853\/2402","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,4]],"date-time":"2023-06-04T04:29:25Z","timestamp":1685852965000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojs.jpma.org.pk\/index.php\/public_html\/article\/view\/9853"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,25]]},"references-count":0,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,5,25]]}},"URL":"https:\/\/doi.org\/10.47391\/jpma.egy-s4-38","relation":{},"ISSN":["0030-9982"],"issn-type":[{"value":"0030-9982","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5,25]]}}}